← Back

CVE-2017-17678

nvd nist
Published: May 19, 2021Modified: Jul 9, 2026

JSON object

Loading...
6.1
Vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Exploitability: 2.8 / Impact: 2.7
Source: NVD

Description

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Affected (1)

Products: Bmc: Remedy Mid Tier
Bmc
1 product
Remedy Mid Tier
Configuration A
1 vulnerable
Vulnerable SoftwareAffected Versions
Remedy Mid Tier
Version 9.1 sp3

Related CWEs

CWE-79
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.

References (4)

Source: cve@mitre.org
Release NotesVendor Advisory
Source: cve@mitre.org
Mailing ListThird Party Advisory
Source: af854a3a-2127-422b-91ae-364da2661108
Release NotesVendor Advisory
Source: af854a3a-2127-422b-91ae-364da2661108
Mailing ListThird Party Advisory

Timeline

No history available yet.